The Art and Science of Options Trading with Blueprint Medicines (BPMC)

Avatar photo

Unlocking Potential with Options Trading

Investors in Blueprint Medicines Corp continue to find themselves at a crossroads of opportunity as new options surface for the May 17th expiration. The seasoned traders at Stock Options Channel have meticulously combed through the BPMC options chain, singling out one put and one call contract that stand out from the crowd.

Delving deeper, the put contract sitting at the $70.00 strike lures investors with a current bid of $1.65. Tempting as it may be, the sale-to-open commitment at $70.00 promises a net cost basis of $68.35 per share, a stark contrast to the current market rate of $86.09 per share.

Leaping at this offer amounts to a 19% discount off the present trading price, a tantalizing possibility of a lower entry point. The put contract’s odds of expiring in vain stand at a formidable 87%, promising a 2.36% return on the investment- a juicy 14.58% annualized return that sets hearts racing.

Visualizing the Landscape

A visual journey through Blueprint Medicines Corp’s last twelve months unveils a rich tapestry of market movements. The tranquil green expanse highlights the pivotal $70.00 strike, offering solace in its strategic location amidst BPMC’s past turbulence:

Loading+chart+—+2024+TickerTech.com

Casting our gaze towards the call options, the $90.00 strike beckons with a bid of $3.70. A savvy investor snagging shares at the current $86.09 level and venturing into selling-to-open territory at $90.00 embraces a dance with fate. This ‘covered call’ maneuver ensures a sumptuous 8.84% return, leaving the door ajar for a plethora of possibilities should BPMC shares soar to the skies. A cautious eye on BPMC’s historic movements combined with fundamental analysis is paramount. Let us peer at BPMC’s intricate journey, with the $90.00 strike shimmering in fiery red hues:

Loading+chart+—+2024+TickerTech.com

Hovering at a 5% premium to the current stock price, the $90.00 strike plays a tantalizing role in the theater of dreams. As the covered call contract contemplates its own worth, the odds of ending fruitlessly hover at a middling 49%. Should the venture end in naught, the investor retains both their shares and the precious premium. The prospective 4.30% return amplifies the investment by 26.59% annually, a bonanza we endearingly call the ‘YieldBoost’.

Imagination runs wild in the put and call realm as the implied volatility for the put contract peaks at 90% and the call contract hovers at a modest 61%. Checking the pulse of the actual trailing twelve-month volatility at 56%, seasoned investors find solace in the ebb and flow of the market. Dive into a sea of put and call option ideas at StockOptionsChannel.com.

Top YieldBoost Calls of the S&P 500 »

Further Exploration:

• BRKR Dividend History
• Top 10 Hedge Funds Holding Comcast
• VTRU Average Annual Return

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now